SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " scan " 869 found 🔀 AI-powered Shuffle
A Major Trump Energy Scandal Is Flying Under the Radar. It’s a Twisted Repeat of History.
The administration wants blue states to heat up a lot more quickly than red states.
Years of scandals haven't stopped Ken Paxton. Can James Talarico change that?
Ken Paxton’s past has been litigated for years, yet he keeps winning. James Talarico is trying a different strategy. Here’s what it is.
Ken Paxton has survived years of scandals. Can James Talarico change that?
Democrat James Talarico is challenging Republican Ken Paxton in a closely watched U.S. Senate race in Texas.
These insect submariners survive depths that should crush them
Lake fly larvae plunge more than 200 meters into Lake Malawi each day to hide from predators, using tiny air sacs to control their depth. A rubber-like material called resilin lets them expand or shrink the sacs by changing their pH. Their toughness challenges a popular explanation for why insects are absent from the open ocean.
Body Scans Are Suddenly Everywhere. Should You Try One?
Inside the wellness trend taking celebrities and influencers by storm.
Years of scandals haven't stopped Ken Paxton. Can James Talarico change that?
Democrat James Talarico is challenging Republican Ken Paxton in a closely watched U.S. Senate race in Texas.
Relocating CT scanners closer to ED cuts turnaround times with potential to save lives
Every minute saved improves patients’ odds of disability-free survival, experts involved in the analysis noted.
Coffee may help shield the liver from fat, scarring, and cancer
A major long-term study linked coffee consumption with lower risks of cirrhosis, liver cancer, and death from liver disease. Coffee drinkers also showed healthier liver scans and blood protein patterns, with less fat, inflammation, and scarring. Benefits appeared even at one or two cups daily and were strongest around three to four cups.
McConnell faces growing questions about absence nearly six weeks after fall
Scant details have not quieted rumors and online speculation about the former Senate Republican leader’s condition.
Maine Democrats are poised to pick their Senate nominee at an unusual party convention
Maine Democrats are poised to pick Troy Jackson as their new Senate nominee on Saturday, the culmination of a brief and unusual contest to replace Graham Platner after he left the battleground race amid scandal.
Democrats in Maine gather to replace Graham Platner in the race against Susan Collins
Democrats are hoping to move past Platner's scandal-plagued campaign as they look to unseat Republican incumbent Susan Collins. The apparent front-runner is former Maine Senate President Troy Jackson.
The big healthcare fight Democrats keep dodging
The real lesson of Abdul El-Sayed’s latest pseudo-scandal.
The big healthcare fight Democrats keep dodging
The real lesson of Abdul El-Sayed’s latest pseudo-scandal.
AI-based exam queue tool prioritizes CT scans in the ED
A new paper in Radiology: Artificial Intelligence details how an AI-driven CT queue prioritization system can improve patients’ time to diagnosis without requiring additional imaging equipment or staffing.
This is Massachusetts' most iconic ice cream shop, according to Business Insider
The publication highlighted a beloved Cambridge destination in its list of the most iconic ice cream shops in every state. Here's why it earned the honor.
WordPress wp2shell Exploitation Grows as Public Exploit Fuels Mass Scanning
Attackers are exploiting two WordPress flaws as wp2shell, chaining them for unauthenticated RCE and deploying web shells and malicious plugins.
Bipartisan Bill Pushes $25M 4D Software for Veterans' Respiratory Health
Lawmakers unveiled a bipartisan bill to invest VA funds into diagnostic scanning software that could detect asthma or lung conditions.
Singapore minister resigns over ‘interactions with a woman’, PM says
The People's Action Party, which prides itself on a clean reputation, has been rocked by a series of scandals recently.
Surrogacy Scandal Upends German Politics
Jens Spahn, a top leader of Chancellor Friedrich Merz’s party, resigned his post after announcing having had a baby by surrogate, which is outlawed in Germany
BYU’s Three Toughest Tests in 2026
The 2026 football season is right around the corner. Fall camp is just a few weeks away and BYU kicks off against Utah Tech in just over 50 days. With that in mind, let’s scan over the football schedule and pinpoint where BYU will be tested the most. Almost no game on the schedule is […]
AI Made Up a Science Term — Now It’s in Dozens of Papers
A scanning mistake and a translation error created scientific nonsense that AI models learned to repeat.
White House operator on leave after betting scandal investigation
Gabriel Perez, White House teleprompter operator, faces a CFTC probe for reportedly earning $100K from bets on Trump's speeches using Kalshi.
Dollar Tree installs customer price scanners for a disheartening reason: ‘Never thought I'd see the day’
How the Milwaukee County pension scandal reshaped Wisconsin politics
The Milwaukee County pension scandal gave rise to the political career of Scott Walker and reshaped Wisconsin politics.
Daniel Ek's body-scanning startup Neko Health raises another $700M
Neko Health has developed proprietary body-scanning technology, which it couples with bloodwork, to assess a person's health.
Daniel Ek’s Neko Health Raises $700 Million From Billionaires, Celebs
Neko Health, Daniel Ek’s startup developing body-scanning technology, has raised $700 million from venture capitalists, billionaires and celebrities to open new facilities, including one in New York later this year.
15 things science says about friendship and what it does to your health
From immune function and blood pressure to brain scans and life expectancy, here is what researchers have found about the ways friendship shapes the body
15 things science says about friendship and what it does to your health
From immune function and blood pressure to brain scans and life expectancy, here is what researchers have found about the ways friendship shapes the body
'Bachelorette' star reveals brain tumor diagnosis after routine health scan
Joe Amabile revealed a routine health scan uncovered a blueberry-sized glioma in his brain, and he now faces a craniotomy in just two weeks.
Astronauts take first X-rays in space
A SpaceX crew scanned a hand and other body parts during a recent mission.
Scientists discovered 31 new deep-sea species off Brazil
Meet some of the 31 new species scientists have identified in what could be record time, off the coast of Brazil.
Algorithm allows cancer patients to avoid CT scans for pulmonary embolism
There has been increased interest in finding alternative methods to diagnose pulmonary embolism in this patient population.
‘Bachelor’ star Joe Amabile reveals diagnosis with early stage brain tumor, will undergo surgery
Beloved ‘Bachelor’ Nation star Joe Amabile says that his doctors detected a ‘blueberry-sized’ tumor in his brain after he underwent a full-body scan. He is scheduled for a craniotomy in two weeks.
2nd PET scan changes treatment for nearly half of prostate cancer patients
Managing recurrent prostate cancer after first-line treatment remains a key clinical challenge, experts write in The Journal of Nuclear Medicine.
Norway's other World Cup campaign: Getting Israel kicked out of soccer - Live Updates
The Scandinavian country is playing a long game in the Middle East, using institutional pressure rather than fan protest or outspoken players to get Israel suspended from FIFA.
Senate hopefuls try to keep Platner at a distance while embracing his movement
In Maine, Democrats vying to take on GOP Sen. Susan Collins are condemning the scandal-tarred former candidate while wrapping their arms around his populist rhetoric and agenda.
Here are the races to watch as Democrats grow more bullish on retaking the Senate
The map still favors Republicans, but political headwinds are shifting to boost Democratic chances of flipping seats — despite the scandal in Maine.
I tried Bryan Johnson's $117,000 brain scanner
Biohacker Bryan Johnson invested $60 million into a brain-tracking headset. How well does it work?
Trump Brushed Off His Scandals. Here’s Why Platner Couldn’t.
Why Democrats can't play by Trump rules.
World Cup 2026: EU lawmakers call for formal investigation into Folarin Balogun 'scandal'
Plus: Englands Anthony Gordon says he took Mexico boss Javier Aguirres foul-mouthed rant as a compliment; Arsenal expected to test Newcastles resolve with a first official bid for Bruno Guimaraes; Lamine Yamal says he hopes to see Julian Alvarez complete a transfer to Barcelona
Jack Latvala, a master of Florida politics sidelined by scandal, dies
Jack Latvala, a towering force in Florida politics whose rise helped shape the GOP and whose fall ended a gubernatorial bid, died at 74.
Christ Hospital Health Network first in country to install, use new CT scanner
The system supports consistent CT imaging to help doctors visualize tumors and plan for treatment.
Princeton collaborators celebrate start of observatory's ‘ultra-high-definition time-lapse record of our Universe’
Princeton researchers have played a major role in developing software pipelines to process the massive amounts of data the Legacy Survey of Space and Time generates as it scans the cosmos.
Maine Democrats plan convention to replace scandal-hit Platner
Senate pick announced his withdrawal in angry video accusing party and media of acting as ‘judge, jury and executioner’
Graham Platner drops his bid for Senate after facing an allegation of rape
Platner's campaign to unseat GOP Sen. Susan Collins in Maine was marked by repeated scandals. It came to a crashing halt after the allegation led top Democrats to withdraw their support.
9 possible candidates who could replace Platner on Maine’s ballot
Will Democrats choose another progressive nominee or distance themselves from Graham Platner’s wing of the party amid his scandals?
Carville blasts Dems amid Platner scandal, warning they ignored a classic rule of politics and paid the price
James Carville blasted Maine Democrats for failing to vet Platner, saying opposition research on your own candidate is the most important step.
GOP leaders tried to quell McConnell health questions. It’s not working
As online speculation swirls over Sen. Mitch McConnell’s hospitalization and scant public updates from his staff, the Kentucky Republican’s top allies spoke up this week, insisting he remains alert. But those assurances have done little to quash demands for proof of life, including from the state’s governor. The episode has reignited a debate over lawmakers’ […]
Today’s Papers – It’s over for Ronaldo, Juventus move for Pellegrino
La Gazzetta dello SportWorld Cup kickedThe scandal of the suspended red cardControversy over the pardon for the American. Trump: ‘Yes, I’ve asked Infantino.’ UEFA: ‘That’s how you lose credi...
Graham Platner's New Scandal and Authenticity's Limits
He said there wouldn’t be any more scandals, but a new Politico report threatens to end his Senate campaign in Maine.
What Trump’s FIFA Scandal Says About His Politics
Now the whole world is getting a lesson in presidential coercion.
Mitch McConnell remains hospitalized after more than three weeks
The former Senate Republican leader’s office has not detailed what led to his hospitalization or the status of his recovery, but police scanner audio shows CPR was performed at his home.
Woman accuses Maine Senate candidate Graham Platner of sexual assault
Democratic candidate for Senate, who has faced series of scandals, denies allegation reported by Politico
What We Know About Senator Mitch McConnell’s Condition
The Kentucky Republican and former Senate majority leader was hospitalized on June 14. Scant details about his condition have emerged since.
Health secretary seeks advice over maternity inquiry staff who refused to give evidence
James Murray says he felt "numb" after hearing from families affected by the scandal.
Franciscan Health’s Marissa Adcock honored at Indiana Child Passenger Safety Conference
Franciscan Health Trauma Services Department Injury Prevention Coordinator Marissa Adcock was recently recognized for her role in helping keep kids safe. Marissa Adcock, injury prevention …
Ireland, as 'honest broker', reckons with the price of dirty business
Ireland is facing the music over its continued sales of alumina to Russia. The scandal put a damper on the start of the country's EU presidency and raised uncomfortable questions that Dublin has yet to answer.
Riley Gaines and women's sports activists share honest reactions, emotions to SCOTUS Title IX ruling
Riley Gaines says the Supreme Court women's sports ruling is worth celebrating but admits the years-long fight has left her deeply exhausted.
Once a source of national pride, Cuba’s healthcare system declines as energy shortages deepen crisis
Irisleydis Tristá, a cancer patient in Cuba, has been unable to get a crucial CT scan for seven months because the machine at Havana’s leading hospital is broken.
PACE Provider myPlace Health Achieves High-Acuity Care Reductions
The SCAN Group affiliate myPlace Health has acheived significant reductions in hospitalizations as its program exceeds 300 participants. The company
Former NBA player Malik Beasley pleads not guilty in gambling scandal
Beasley is the latest charged in a growing sports gambling probe led by prosecutors in the Eastern District of New York.
Vanderbilt Health performs nation’s first breast cancer surgery using intraoperative PET-CT scan technology
The novel imaging technology provides surgical teams with a real-time view of tumor margins in the operating room.
DR Congo health workers battle Ebola despite scant protection
In Ituri, DR Congo's Ebola epicenter, overwhelmed clinics and a lack of protective gear leave health workers exposed as the outbreak spreads beyond control.
Radiology providers must pay $7M, modify policies after breast cancer miss
Radiologist Henry C. Lusane, MD, with Acumen Medical Imaging, interpreted the scans, reporting the mass as benign, a mistake later leading to a terminal cancer diagnosis.
Apple Is Moving The iPhone 18 Pro’s IR Flooder To The Side, As A CT Scan Exposes A Huge Vapor Chamber Stretching To The Top, And A Smaller Dynamic Island
Apple has moved iPhone 18 Pro's infrared flooder to the side, while housing the front camera and the Face ID scanner within a smaller cutout.
Doctors thought man had brain cancer — they found live tapeworms instead
Doctors suspected metastatic brain cancer in a 60-year-old man, but scans revealed pork tapeworm larvae causing neurocysticercosis.
Milei Taps Lifetime Politician to Lead His Cabinet After Scandal
Argentine President Javier Milei tapped a seasoned politician he once openly insulted on the campaign trail to become the fourth cabinet chief of his government plagued by corruption scandals.
Science & Medicine: Scanning the brain to improve treatment for traumatized teens
Around 20% of teens who have experienced emotional trauma don't respond to talk therapy. UT Health San Antonio is using neuroimaging to track brain changes in traumatized teens during a course of therapy to see if they can figure out why, which could lead to the development of more personalized treatments that will help more teens heal.
The fittest founder in the room got cancer. Here's how he used AI to fight back.
When confronted with cancer, Connor Christou fed everything tied tied to his regime — blood results, scan data, wearable output, journal entries — into Claude.
New vitamin B12 therapy shows promise against deadly brain cancer
Researchers have identified a vitamin B12–based compound that can cross the blood-brain barrier and home in on glioblastoma tumors. In animal studies, the compound accumulated preferentially in tumor tissue and delivered sustained nitric oxide directly to cancer cells. It also worked synergistically with existing glioblastoma treatments, significantly enhancing their tumor-fighting effects.
‘A total fairytale’: Former Watergate prosecutor reacts to Vance’s comments on the scandal
Vance Downplays Watergate and Compares Himself to Nixon
The vice president said that the scandal that ended Richard Nixon’s presidency would be “like a 12-hour news story” if it happened today and that the “deep state” had taken down Nixon.
Karl Stefanovic Speaks Out on Nine Exit After Tommy Robinson Scandal
The 'Today' host declares himself 'free' in a YouTube statement after Nine ends his contract following a deleted Tommy Robinson podcast episode.
Vance dismisses Watergate scandal, says ‘deep state’ went after Nixon
The vice president said he admired Nixon and drew parallels between the past president, who resigned amid pressure in 1974, and Trump today.
JD Vance says Nixon’s Watergate scandal would be ‘12-hour news story’ today
Vice-president declares admiration for 37th president and claims Nixon and Trump targeted by ‘deep state’ forces
Vance, an admirer of Richard Nixon, says Watergate would be 'a 12-hour news story' today
Vice President JD Vance says the Watergate scandal that brought down President Richard Nixon would have been a blip in today’s news cycle
Making Our Own Luck
We are cross-posting a piece that former NIH official Kris Willis wrote for Macroscience. Kris is now the President and Founder of the Woodley Park Institute, for which I’m a board member. Picking winners or hedging bets? Federal science agencies have long wrestled with the question of how to ensure their billions of dollars of grants and contracts result in maximum benefits for Americans. On the surface, it might seem that a goal-oriented, interventionist style of management would be the best policy: prioritize our most pressing problems and distribute funding accordingly.This top-down strategy creates a unique hazard, though: bad choices can send resources in the wrong direction, resulting in slow progress that impedes the delivery of tangible benefits to citizens. Moreover, if decision makers pursue an applied advance when the underlying scientific principles remain poorly understood, they risk costly failures and a loss of support for the research enterprise at large. Examples include Nixon’s 1971 War on Cancer, undertaken on the premise that a cure could be achieved in less than a decade, the drive to build an operational commercial fusion plant by the mid-1990s, and the National Plan to Address Alzheimer’s Disease, which failed to produce the effective treatments and prevention strategies promised by 2025. The contrasting laissez-faire approach is to hedge your bets. If the path to an advance is impossible to predict, then the wisest choice might be to distribute funding to as widely as possible. The main risk of this strategy is that spreading funding thinly may limit the resources available to the most promising research, resulting in the same negative outcomes as the interventionist approach: limited support for the most promising topics, slow progress, and delayed returns. In reality, at science agencies like the National Science Foundation and National Institutes of Health, program managers navigate between these two extremes, setting some funds aside to target high-priority areas and using the rest to cover the widest possible range of meritorious proposals. This middle path seems like the most rational way to proceed, but it still requires making choices. How much should be set aside for high priority topics? What should those topics be? How should we define merit? Expert opinion can provide a helpful guide, but leading experts can have remarkably different opinions about what matters and what should be prioritized. Moreover, experts and administrators alike can be risk averse, giving an edge to high-profile, well-established concepts. What’s really needed is a data-driven framework to help guide decision-making, one that doesn’t simply repackage prestige or incumbency. Recognizing breakthroughs years in advance Many breakthroughs fail to attract funding or recognition at the earliest stages of development. Katalin Karikó, for example, spent years struggling to win grants for work on mRNA that would eventually win her and Drew Weissman a Nobel Prize. Similar stories can be told about Jim Allison’s groundbreaking studies leading to the development of cancer immunotherapy, Stan Pruisner’s demonstration that prions can self-replicate without DNA, or Robin Warren and Barry Marshall’s proof that Helicobacter pylori, not stress, causes ulcers. Yet at some point, the scientific community recognizes and responds to transformative breakthroughs like these. How does that change happen? And what if science funders could identify the areas that are on the cusp of a breakthrough? Those questions led my collaborators and me to study how scientists responded to past breakthroughs. Based on patterns in that data, we developed a means of predicting future breakthroughs, using biomedicine as a proof of concept. It’s worth taking a moment to describe how our approach works. Briefly, our prediction process begins by grouping the 18 million or so peer-reviewed papers in PubMed, the authoritative database of biomedical research, into roughly 50,000 unique topics. A small subset of these topics are so widely acclaimed as breakthroughs that they have been recognized with a major prize like a Nobel or a Lasker Award. We theorized that studying the development of these outliers over time, especially before they gained acclaim, was the key to identifying future instances of them. After defining topics, we chose 21 representative breakthroughs and asked what they looked like before they won prestigious prizes. To answer that question, we re-ran our topic-mapping algorithm repeatedly, winding back the clock one year each time, stringing together the years to follow the progress of each field as it grew and advanced. We found that in each case, the years leading up to a discovery followed a pattern: a burst of papers on a new, rapidly evolving topic, many of which quickly became influential. These characteristics—the percent of papers that are new, the percentage of papers that are brought in from other topics, and the influence of each individual paper—can all be measured separately for any given topic. Together, they act as a predictive signal that is detectable an average of five years before a transformative discovery is made, and up to thirty years before the discovery receives a major prize. Scanning the current research landscape for topics that display this signal allows us to predict what work will likely produce a future breakthrough. Each year we analyzed includes four or five signals, a number that appears to have remained constant across a twenty year time frame. In their classic work on the sociology of science, Bruno Latour and Steve Woolgar established that the desire to participate in a major discovery is an important motivator for scientists as they consider whether they should take up (or abandon) a research problem. Although further work is needed, the simplest explanation for our results is that this behavior is widespread enough to detect at scale. A foundational advance, or something like it, draws the attention of scientists and causes them to change the direction of their research. They vote with their feet, staking their own reputation and careers by publishing on and citing the new idea. That upswell of interest is the foundation of our breakthrough signal. What kind of research does our model identify as a breakthrough? After building a model based on the patterns in our 21 preselected breakthroughs, we tested it by identifying all early signals of discovery from 1994 through 1997. Of the 18 signals we found in that time period, 17 can be traced forward in time to a breakthrough. Examples include super-resolution fluorescence microscopy (see the image above), the directed evolution of proteins and enzymes (Chemistry Nobel, 2018), and sequencing the human genome (National Medal of Science, 2008). The discovery of the role of leptin signaling in obesity is a particularly interesting case study. Around 1950, scientists noticed the existence of a type of lab mouse that suffered from a unique inherited form of obesity. When given the freedom to choose their own diet, these mice ate more than normal and preferred food that was high in fat. Researchers had few clues as to why the animals overate; early experiments pointed to the existence of a soluble ob factor found circulating in the bloodstream that regulated appetite, but its identity was unknown. In 1994, Jeffrey Friedman and colleagues identified and sequenced the ob gene, noting that the protein it encoded appeared to fit the profile of a circulating factor. A year later, a trio of high-profile publications demonstrated that ob was a hormone that regulated body weight and fat deposition by regulating appetite. One of these was co-authored by Friedman, who christened it leptin from the ancient Greek word for thin. Using our model, the data from 1996 make it clear this advance would become a breakthrough. Scientists had flocked to study the biology of the new hormone, generating the flurry of new papers and citations required to produce a signal. One of these demonstrated that serum leptin concentrations reflected the amount of adipose tissue in the human body, providing clinical validation of the earlier mouse studies. Before the identification of leptin, scientists were unable to point to a specific molecule that controlled appetite and adiposity, so that it was impossible to rule out non-physiological causes of obesity; its characterization fundamentally changed our concept of weight gain. In 2010, Friedman and fellow pioneer Douglas Coleman were awarded a Lasker for the discovery. Our work also identifies breakthroughs in clinical practice and behavioral and social sciences, even though these areas are less likely to draw the attention of major prize committees. One example that falls into this category is the introduction of endovascular aneurysm repair, a minimally invasive surgical procedure for the treatment of abdominal aortic aneurysm, a leading cause of death among Americans over the age of 65. Relative to the previous standard of care, it reduces in-hospital mortality by almost four-fold. In 2017, Timothy Chuter received the American College of Surgeons’ prestigious Jacobsen Innovation award for his multiple refinements to the technique. Another under-recognized breakthrough identified by our model is the development of standardized survey instruments to assess the quality of life for HIV+ patients. The antiretroviral cocktails introduced in the mid-1990s reduced AIDS mortality, but treatment came with serious side effects. The new evaluations showed that patients whose disease progressed had worse physical functioning than Americans with other chronic diseases, while those who were asymptomatic maintained a health-related quality of life on par with the overall US population. This evidence made it possible for patients and activists to argue that even in the absence of a total cure, and in spite of the side effects, alleviation of symptoms was a worthwhile priority for clinicians. My colleagues and I have failed to identify any significant recognition for the physicians and health policy experts who pioneered this advance, although in 2016, researchers called for the World Health Organization to set targets for good health-related quality of life as part of its framework to end the AIDS pandemic. From forecasting to funding How should science funders use our predictions? Any serious discussion of what we should do with this new capability needs to begin with an understanding of its limitations. We can’t (and shouldn’t) invest all of our resources in the small number of topics predicted to produce breakthroughs. Innovative new fields are born from existing ones; they rarely arise de novo. If funders don’t maintain a diverse portfolio, the breakthroughs of tomorrow will have no antecedents. Think of this as eating the seed corn, or killing the goose that lays the golden egg. There are also multiple goals of funding beyond basic scientific discovery, including translating discoveries into clinical practice, developing new technologies, supporting economic development, and training new scientists. The investments needed to accomplish these goals are likely different from those required to support emerging breakthroughs. Finally, we must be aware that we may not capture every instance of a breakthrough. The concept is fuzzy, and not every significant discovery is recognized with a major award. Further, breakthroughs are rare, meaning that our dataset is, by necessity, small. This makes formal estimates of accuracy challenging. Although our overall success rate appears to be high, any one signal may turn out to be a false positive. We found one apparent example: the development of the third generation COX-2 inhibitors, Vioxx and Celebrex, which were much celebrated in the early 2000s as effective but non-addictive pain relievers, meets all the algorithmic criteria of a breakthrough. Five years after it received FDA approval, researchers demonstrated that Vioxx was associated with serious cardiovascular complications, and the manufacturer voluntarily pulled the drug from the market. Celebrex remains available, although like other NSAIDs, it carries an FDA warning for increased cardiovascular risk. Decision makers who were overly focused on the breakthrough potential of this research might have wasted substantial resources nurturing an area that ultimately proved to be a failure—but so would those who relied on expert opinion at the time. That said, the potential benefits of funding the next mRNA vaccine or cancer immunotherapy years earlier than we might have are large. When we can’t assume the outcome of an action, it’s worth conducting an experiment. Can targeted support for areas that are poised to produce a breakthrough increase the return on scientific investment without cannibalizing future advances? With the necessary administrative infrastructure in place, conducting this experiment would be straightforward. First, identify all the breakthrough signals between 2018 and 2023, select half at random, and commit to a decade of investment. For biomedicine, a six year window should yield about 30 topics with the potential to produce a breakthrough. Providing strong support to half of these might be accomplished for $300 million a year. That’s roughly half of the recent annual budget of the NIH Common Fund or around 20% of the fiscal year 2025 budget for ARPA-H. After five years, then again at ten, compare to see which group — the one that was actively managed, or the control — produced more breakthroughs, and on what timescale. Although we used biomedicine as an example, the same experiment could just as well be run for physics, materials science, or any other discipline. Any attempt to undertake such an experiment should keep three points top of mind. First, we can predict the topic of future breakthroughs, but the people and vision for how to move the work forward are still important. In practice, this means success requires active program managers with the expertise to develop the science and the authority to do so, including by recruiting investigators. Second, we would be wise to learn from the failures of past attempts to fund transformative research. High among these are funding modestly repackaged work, confusing the genuinely novel with the merely unfamiliar, and relying too much on incumbent investigators. All of these risks can be mitigated by thoroughly and intelligently integrating high quality data into portfolio management. Finally, we need to have patience. Even with strong funding support, producing a breakthrough takes time. If supporting breakthroughs is the best way to nurture the birth of new fields, we also need to accurately describe and properly manage the other two stages, so that we invest wisely throughout the productive lifetime of ideas and divest once they reach the point of diminishing returns. We would benefit from more study of all of these phases, especially the transition from one to another. More research could answer questions like: When does a breakthrough become an established field? How do the availability of funding, the size and characteristics of the available workforce, and the accumulation of evidence that disagrees with prevailing models affect a field’s decline? Exactly how do old ideas give birth to new ones, and can we speed up the process? The more we understand about the dynamics of scientific progress, the better we can maximize the odds that our curiosity leads to results. I’d call that finding a way to make our own luck.
Brooklyn coffee shop that targeted Jewish congressman faces DOJ probe after reported tax, health code issues
Poetica Coffee owner Parviz Mukhamadkulov donated to scandal-plagued candidate Graham Platner and reportedly faces tax debts and health code violations.
A scientist says he can scan prisoners’ brains for signs of evil. Did his disputed science put a man on death row?
Kent Kiehl convinced the US legal system he can find violence in prisoners’ brains. His theories have been since used by defense lawyers – with grave consequences for prisoners
X-Ray Specs for the World’s Oldest, Sealed Letters
A team of historians, scientists and engineers has developed a portable X-ray scanner to study 4,000-year-old letters encased in clay envelopes.
Moment of Science: “Antscan” project uses particle accelerator to map small insects in 3-D
It's the world of ants like you've never seen it before! Dan Smith shows how biology and particle physics are teaming up in the "Antscan" project. 🐜
Wyze’s new smart scale can break down your body composition for less than $80
The BodyScan is $40 cheaper than Wyze’s Ultra model by ditching Wi-Fi and simplifying the display.
Wyze Scale BodyScan tracks more than just your weight, has Google Health support, $79.98
Wyze is today launching a new scale that tracks more than just your weight while also being affordable, with the...
Business briefs: Franciscan employee honored, United Way offers grants
Business news from around the region.
Federal jury convicts former owner of chiropractic business in Libertyville of defrauding insurance out of $600K
A former owner of a chiropractic business in Libertyville faces prison after a jury convicted him of defrauding an insurance company out of over $600,000 in non-existent services.
Franciscan Health Spirited Celebration Friday October 9th
This October, you’re invited to a night of elegance, celebration, and community impact. Join Franciscan Health as we honor 150 years of healthcare ministry from the Sisters of St. Francis of Perpetual Adoration at the Spirited Celebration Gala! It all happens Friday, October 9th at 6 PM at the Center for Visual & Performing Arts in Munster. Enjoy a cocktail hour, plated dinner, live music, DJ, dancing, photo booth, plus silent and live auctions, wine and whiskey pulls, and incredible entertainment — including Ric Federighi and WIMS Radio, Chris Florek & Ever After Entertainment, and more. Tickets are $250, with
Think human anatomy is finished? Scientists say think again
Despite centuries of study, scientists are still finding new details and even overlooked structures within the human body. As researchers explore anatomical differences between individuals, it’s becoming clear that the body is far more complex—and less fully understood—than textbooks suggest.
The Science Behind Aldi's Exploding Turkey Burger Scandal
A few years ago Aldi had to contend with a lawsuit regarding an exploding turkey burger. Here's the science behind why that incident unfortunately occurred.
Cowboys 2026 roster rundown: WR Marquez Valdes-Scantling
Do you think MVS will fight his way onto the Cowboys roster?
ZenniHome ex-business partner accuses Bob Worsley of creating LLC ‘without her consent’
After eight long days of investigating, the Navajo Nation Council has paused its public hearing into the ZenniHome scandal until next month. But in subpoenaed testimony from earlier this week, a key witness made a bombshell allegation against her ex-business partner.
Fire Vitello Immediately
Vitello knew. And he has to go if this franchise has any hope of moving on from this scandal.
Trump-endorsed pastor suspends Oklahoma House campaign after texting scandal
Megachurch pastor Jackson Lahmeyer ended his bid after advancing in a runoff. A British tabloid alleged he had an inappropriate relationship with a former staffer.
Pastors for Trump founder withdraws from US House race after texting scandal
Pastors for Trump founder Jackson Lahmeyer on Wednesday announced he was ending his bid for Oklahoma’s 1st Congressional District, one day after he was projected to advance to a runoff for the Republican nomination in the wake of a texting scandal.
What hospitals are preparing for during World Cup
Measles? A food poisoning outbreak or a need for lots of CT scans in a hurry? With the World Cup in town, hospitals and public health teams say they're prepared.
Deion Sanders' Son Ready To Get His Health Checked After Cancer Survivor Father's New Initiative
Deion Sanders’ health scare began with a routine scan, the kind that most men would rather delay. Fortunately, it caught his bladder cancer early, and now the Colorado head coach is trying to push that lesson onto other men, starting with his eldest son.
Todd Blanche is no sure thing in looming AG nomination battle
Past scandals and a history of personal service to Trump are complicating the president’s pick to lead the Justice Department
Designing The Future 3: Inside The Ocean Expedition That Used Lasers To Discover 31 New Species
The Designing the Future 3 expedition used 3D laser scanning to study gelatinous deep-sea animals in their natural habitat, building a new blueprint for how we document ocean life.
Armie Hammer explains how 'old Jamaican guy' helped quiet his anger over famous friends' lack of support
Armie Hammer explained how an 'old Jamaican guy' helped him get over the anger of his famous friends failing to publicly support him through his abuse scandal.
Oprah Winfrey blesses new CT scanner she helped fund in Hawaii
Maui Memorial Medical Center, a 214-bed acute care hospital in Wailuku, celebrated the new computed tomography machine with its imaging team on June 8.